Nobuya Inagaki Selected Research

Nobuya Inagaki Research Topics

Disease

101	Type 2 Diabetes Mellitus (MODY) 03/2024 - 10/2005
32	Body Weight (Weight, Body) 01/2023 - 12/2007
31	Insulin Resistance 01/2023 - 06/2005
29	Hypoglycemia (Reactive Hypoglycemia) 01/2024 - 09/2006
27	Obesity 01/2023 - 04/2008
25	Hyperaldosteronism (Conn Syndrome) 05/2023 - 10/2015
19	Diabetes Mellitus 01/2022 - 01/2006
17	Neoplasms (Cancer) 10/2023 - 01/2013
16	Hyperglycemia 01/2024 - 01/2006
16	Glucose Intolerance 12/2022 - 12/2005
12	Insulinoma 01/2023 - 04/2011
8	Adenoma (Adenomas) 05/2023 - 03/2018
8	Hypertension (High Blood Pressure) 01/2021 - 04/2008
6	Weight Gain 07/2019 - 07/2015
6	Hypoxia (Hypoxemia) 05/2015 - 06/2002
5	Hypothyroidism 10/2023 - 01/2017
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2023 - 11/2015
5	Sarcopenia 08/2023 - 01/2017
5	Hypokalemia 05/2023 - 01/2018
5	Heart Failure 04/2023 - 04/2020
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2018
5	Weight Loss (Weight Reduction) 12/2022 - 10/2010
5	Disease Progression 02/2022 - 11/2009
4	Rheumatoid Arthritis 08/2023 - 01/2020
4	Nausea 02/2022 - 01/2020
4	Constipation 02/2022 - 10/2011
4	Inflammation (Inflammations) 01/2019 - 08/2002
4	Diabetes Complications 08/2018 - 09/2008
4	Seizures (Absence Seizure) 12/2017 - 06/2002
4	Atherosclerosis 01/2017 - 04/2007
3	Thyrotoxicosis 10/2023 - 01/2017
3	Prediabetic State (Prediabetes) 01/2023 - 01/2019
3	Neoplasm Metastasis (Metastasis) 01/2023 - 03/2018
3	Respiratory Insufficiency (Respiratory Failure) 02/2022 - 06/2008
3	Adrenal Insufficiency (Adrenal Gland Hypofunction) 02/2022 - 12/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2020 - 01/2013
3	Overweight 01/2020 - 10/2014
3	Diabetic Nephropathies (Diabetic Nephropathy) 06/2017 - 01/2014

Drug/Important Bio-Agent (IBA)

67	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 12/2005
41	Insulin (Novolin)FDA Link 01/2023 - 06/2006
20	Hypoglycemic Agents (Hypoglycemics)IBA 04/2023 - 09/2007
19	AldosteroneIBA 05/2023 - 10/2015
19	CanagliflozinIBA 01/2022 - 08/2014
15	SodiumIBA 02/2023 - 08/2014
13	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2023 - 05/2014
12	Blood Glucose (Blood Sugar)IBA 12/2022 - 12/2006
12	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 02/2008
11	IncretinsIBA 11/2019 - 06/2009
10	SymportersIBA 02/2023 - 08/2014
10	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 02/2008
10	LipidsIBA 08/2018 - 10/2005
9	Hydrocortisone (Cortisol)FDA LinkGeneric 03/2024 - 12/2017
9	Peptides (Polypeptides)IBA 01/2023 - 09/2014
9	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2022 - 06/2009
8	Exenatide (Byetta)FDA Link 10/2023 - 09/2011
8	Triglycerides (Triacylglycerol)IBA 01/2023 - 10/2005
7	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2023 - 09/2012
7	ReninIBA 01/2022 - 10/2015
7	Adenosine Triphosphate (ATP)IBA 11/2011 - 06/2002
6	gastric inhibitory polypeptide receptorIBA 01/2023 - 12/2007
6	Sodium-Glucose Transport ProteinsIBA 12/2022 - 05/2014
6	AdiponectinIBA 01/2020 - 10/2005
5	Adrenocorticotropic Hormone (ACTH)FDA Link 09/2022 - 12/2017
5	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2022 - 12/2007
5	trelagliptinIBA 03/2018 - 02/2014
5	Proteins (Proteins, Gene)FDA Link 01/2018 - 05/2005
4	Hormones (Hormone)IBA 03/2024 - 09/2014
4	Growth Hormone (Somatotropin)IBA 08/2023 - 01/2018
4	LinagliptinIBA 02/2023 - 11/2016
4	dulaglutideIBA 02/2023 - 12/2016
4	Mineralocorticoid Receptor AntagonistsIBA 01/2022 - 01/2019
4	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 01/2022 - 01/2017
4	PotassiumIBA 01/2021 - 04/2007
4	Glucagon (Glukagon)FDA Link 11/2020 - 05/2011
4	CarbohydratesIBA 01/2020 - 11/2015
4	Hemoglobins (Hemoglobin)IBA 11/2017 - 01/2015
4	C-PeptideIBA 01/2017 - 08/2008
4	1,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA 04/2016 - 01/2015
3	HomocysteineIBA 08/2023 - 06/2011
3	EnzymesIBA 05/2023 - 10/2014
3	empagliflozinIBA 02/2023 - 06/2014
3	Biomarkers (Surrogate Marker)IBA 12/2022 - 05/2012
3	Thyroid HormonesIBA 01/2022 - 01/2018
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 11/2020
3	alogliptinIBA 01/2021 - 09/2014
3	Insulin Glargine (Lantus)FDA Link 01/2020 - 09/2012
3	LDL CholesterolIBA 01/2019 - 01/2013
3	HDL CholesterolIBA 01/2018 - 10/2005
3	GlucocorticoidsIBA 03/2017 - 08/2016
3	BiguanidesIBA 01/2017 - 06/2014
3	LeptinIBA 01/2017 - 10/2005
3	CytokinesIBA 01/2017 - 10/2016

Therapy/Procedure

51	Therapeutics 10/2023 - 09/2007
16	Glycemic Control 12/2022 - 04/2008
9	Adrenalectomy 01/2021 - 12/2017
6	Islets of Langerhans Transplantation 01/2023 - 09/2006
4	Drug Therapy (Chemotherapy) 03/2023 - 09/2007
4	Aftercare (After-Treatment) 01/2021 - 11/2017
3	Transplantation 10/2023 - 12/2006
3	Diet Therapy (Therapy, Diet) 01/2023 - 12/2019